Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.
You almost got this right…
It's more like, your mother submitted DNA and she's predisposed, so YOU get denied. And that will go back a few generations.
And when it's something like a 2nd cousin submits DNA and is predisposed, they won't deny you specifically, but they'll raise your rates without letting you know why.